Locations:
Search
$1.1M award expands follow-up to six years with focus on clinical endpoints
Guidance for the 5% to 20% of patients with suboptimal response or tolerability
Diagnosis and treatment of MOG antibody-associated disease
Care guidelines have been crucial to progress in TBI care over the past 25 years
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Mounting evidence of possible shared genetic predisposition
Recently launched first-of-kind study aims to address an unmet therapeutic need
Biomarker promises a practical way to reduce misdiagnoses
AHA scientific statement offers best practices to improve care for high-risk populations
Relapse rates were lower with oral or infusion therapy after initial injectable DMT
No notable difference in reactions with two-hour infusion in ENSEMBLE PLUS substudy
Advertisement
Advertisement